BNP PARIBAS FINANCIAL MARKETS - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 280 filers reported holding GW PHARMACEUTICALS PLC in Q4 2020. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q1 2021$206,272,000
-65.2%
951
-81.5%
0.00%
-100.0%
Q4 2020$592,515,000
-41.6%
5,134
-50.7%
0.00%0.0%
Q3 2020$1,013,998,000
+614.8%
10,416
+801.0%
0.00%
Q2 2020$141,864,000
-23.1%
1,156
-45.1%
0.00%
Q1 2020$184,422,000
-76.2%
2,106
-71.6%
0.00%
-100.0%
Q4 2019$774,476,000
+99.3%
7,407
+119.2%
0.00%0.0%
Q3 2019$388,686,000
+401.0%
3,379
+650.9%
0.00%
Q2 2019$77,576,000
+2.3%
4500.0%0.00%
Q1 2019$75,856,000
-62.8%
450
-78.5%
0.00%
Q4 2018$203,935,000
-1.6%
2,094
+74.5%
0.00%
Q3 2018$207,288,000
+23.8%
1,2000.0%0.00%
Q2 2018$167,448,000
+639.4%
1,200
+497.0%
0.00%
Q1 2018$22,647,000
+2351.0%
201
+2771.4%
0.00%
Q4 2017$924,000
-99.5%
7
-99.6%
0.00%
Q3 2017$169,793,000
+4.1%
1,673
+2.8%
0.00%
Q2 2017$163,107,000
+179138.5%
1,627
+162600.0%
0.00%
Q3 2015$91,000
-99.8%
1
-99.8%
0.00%
Q2 2015$55,155,0004490.00%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q4 2020
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 390,000$45,010,0007.31%
Copernicus Capital Management, LLC 2,788$322,0005.02%
Integral Health Asset Management, LLC 72,500$8,367,0002.49%
Parkman Healthcare Partners LLC 81,573$9,414,0002.41%
AdvisorShares Investments LLC 66,317$7,654,0001.78%
Tri Locum Partners LP 40,159$4,635,0001.68%
ETF MANAGERS GROUP, LLC 621,361$71,711,0001.57%
Redmile Group, LLC 815,681$94,138,0001.14%
Redwood Investments, LLC 108,999$12,580,0001.07%
ROOSEVELT INVESTMENT GROUP LLC 127,885$14,759,0001.05%
View complete list of GW PHARMACEUTICALS PLC shareholders